Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Written By Charlotte Kirby
Charlotte Kirby
Previous

Healx launches partnership with Ataxia UK and FARA to find treatments for rare neurodegenerative condition
Next

Privitar Launches New, Seamless Native Pattern to Protect Sensitive Data on AWS